Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes

NCT02380521 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Exenatide once weekly (BYDUREON™)

Sponsor

University of Palermo

Collaborators

[object Object]